These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 20651146)

  • 1. Reactivation of hepatic EPO synthesis in mice after PHD loss.
    Minamishima YA; Kaelin WG
    Science; 2010 Jul; 329(5990):407. PubMed ID: 20651146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia Signaling Cascade for Erythropoietin Production in Hepatocytes.
    Tojo Y; Sekine H; Hirano I; Pan X; Souma T; Tsujita T; Kawaguchi S; Takeda N; Takeda K; Fong GH; Dan T; Ichinose M; Miyata T; Yamamoto M; Suzuki N
    Mol Cell Biol; 2015 Aug; 35(15):2658-72. PubMed ID: 26012551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct subpopulations of FOXD1 stroma-derived cells regulate renal erythropoietin.
    Kobayashi H; Liu Q; Binns TC; Urrutia AA; Davidoff O; Kapitsinou PP; Pfaff AS; Olauson H; Wernerson A; Fogo AB; Fong GH; Gross KW; Haase VH
    J Clin Invest; 2016 May; 126(5):1926-38. PubMed ID: 27088801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolyl-4-hydroxylase 2 and 3 coregulate murine erythropoietin in brain pericytes.
    Urrutia AA; Afzal A; Nelson J; Davidoff O; Gross KW; Haase VH
    Blood; 2016 Nov; 128(21):2550-2560. PubMed ID: 27683416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of HIF-prolyl 4-hydroxylases 1, 2 and 3 in NG2-expressing cells induces HIF2-mediated neurovascular expansion independent of erythropoietin.
    Urrutia AA; Guan N; Mesa-Ciller C; Afzal A; Davidoff O; Haase VH
    Acta Physiol (Oxf); 2021 Jan; 231(1):e13547. PubMed ID: 32846048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-inducible factor prolyl-4-hydroxylation in FOXD1 lineage cells is essential for normal kidney development.
    Kobayashi H; Liu J; Urrutia AA; Burmakin M; Ishii K; Rajan M; Davidoff O; Saifudeen Z; Haase VH
    Kidney Int; 2017 Dec; 92(6):1370-1383. PubMed ID: 28847650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolyl-4-hydroxylases 2 and 3 control erythropoietin production in renin-expressing cells of mouse kidneys.
    Broeker KAE; Fuchs MAA; Schrankl J; Lehrmann C; Schley G; Todorov VT; Hugo C; Wagner C; Kurtz A
    J Physiol; 2022 Feb; 600(3):671-694. PubMed ID: 34863041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIF-1α is a protective factor in conditional PHD2-deficient mice suffering from severe HIF-2α-induced excessive erythropoiesis.
    Franke K; Kalucka J; Mamlouk S; Singh RP; Muschter A; Weidemann A; Iyengar V; Jahn S; Wieczorek K; Geiger K; Muders M; Sykes AM; Poitz DM; Ripich T; Otto T; Bergmann S; Breier G; Baretton G; Fong GH; Greaves DR; Bornstein S; Chavakis T; Fandrey J; Gassmann M; Wielockx B
    Blood; 2013 Feb; 121(8):1436-45. PubMed ID: 23264599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical Characterization of Vadadustat (AKB-6548), an Oral Small Molecule Hypoxia-Inducible Factor Prolyl-4-Hydroxylase Inhibitor, for the Potential Treatment of Renal Anemia.
    Zuk A; Si Z; Loi S; Bommegowda S; Hoivik D; Danthi S; Molnar G; Csizmadia V; Rabinowitz M
    J Pharmacol Exp Ther; 2022 Oct; 383(1):11-24. PubMed ID: 35926869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematological, hepatic, and retinal phenotypes in mice deficient for prolyl hydroxylase domain proteins in the liver.
    Duan LJ; Takeda K; Fong GH
    Am J Pathol; 2014 Apr; 184(4):1240-1250. PubMed ID: 24508125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrity of the prolyl hydroxylase domain protein 2:erythropoietin pathway in aging mice.
    Li X; Sutherland S; Takeda K; Fong GH; Lee FS
    Blood Cells Mol Dis; 2010 Jun; 45(1):9-19. PubMed ID: 20400342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins.
    Takeda K; Aguila HL; Parikh NS; Li X; Lamothe K; Duan LJ; Takeda H; Lee FS; Fong GH
    Blood; 2008 Mar; 111(6):3229-35. PubMed ID: 18056838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of the sensory and regulatory pathways controlling cellular iron metabolism in unilateral obstructive nephropathy.
    Votava JA; Reese SR; Deck KM; Nizzi CP; Anderson SA; Djamali A; Eisenstein RS
    Am J Physiol Renal Physiol; 2022 Jan; 322(1):F89-F103. PubMed ID: 34843656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoic acid regulates erythropoietin production cooperatively with hypoxia-inducible factors in human iPSC-derived erythropoietin-producing cells.
    Katagiri N; Hitomi H; Mae SI; Kotaka M; Lei L; Yamamoto T; Nishiyama A; Osafune K
    Sci Rep; 2021 Feb; 11(1):3936. PubMed ID: 33594180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis.
    Liu Q; Davidoff O; Niss K; Haase VH
    J Clin Invest; 2012 Dec; 122(12):4635-44. PubMed ID: 23114598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonclinical Characterization of the Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat, a Novel Treatment of Anemia of Chronic Kidney Disease.
    Del Balzo U; Signore PE; Walkinshaw G; Seeley TW; Brenner MC; Wang Q; Guo G; Arend MP; Flippin LA; Chow FA; Gervasi DC; Kjaergaard CH; Langsetmo I; Guenzler V; Liu DY; Klaus SJ; Lin A; Neff TB
    J Pharmacol Exp Ther; 2020 Aug; 374(2):342-353. PubMed ID: 32487538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of erythropoietin deficiency in mice with systemically administered siRNA.
    Querbes W; Bogorad RL; Moslehi J; Wong J; Chan AY; Bulgakova E; Kuchimanchi S; Akinc A; Fitzgerald K; Koteliansky V; Kaelin WG
    Blood; 2012 Aug; 120(9):1916-22. PubMed ID: 22611156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-induced erythropoietin production: a paradigm for oxygen-regulated gene expression.
    Stockmann C; Fandrey J
    Clin Exp Pharmacol Physiol; 2006 Oct; 33(10):968-79. PubMed ID: 17002676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for binding of the renal carcinoma target hypoxia-inducible factor 2α to prolyl hydroxylase domain 2.
    Figg WD; Fiorini G; Chowdhury R; Nakashima Y; Tumber A; McDonough MA; Schofield CJ
    Proteins; 2023 Nov; 91(11):1510-1524. PubMed ID: 37449559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TP0463518, a novel inhibitor for hypoxia-inducible factor prolyl hydroxylases, increases erythropoietin in rodents and monkeys with a good pharmacokinetics-pharmacodynamics correlation.
    Kato S; Takayama N; Takano H; Koretsune H; Koizumi C; Kunioka EI; Uchida S; Takahashi T; Yamamoto K
    Eur J Pharmacol; 2018 Nov; 838():138-144. PubMed ID: 30179610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.